Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.
on Ozempic's ability to delay the progression of chronic kidney disease is among the strongest supporting evidence for secondary uses of the drug.on Tuesday. According to the company's press release, it happened more than a year after an interim analysis showed that Ozempic could treat chronic kidney disease in Type 2 diabetic patients.Patel believes efficacy is just one of the major hurdles the medication needs to clear before it can be approved for uses outside of diabetes management.
Patients opting to use GLP-1 drugs — a group of medications initially designed to control diabetes — for weight management often must pay out-of-pocket. If the U.S. Food and Drug Administration approves Ozempic for use in Type 2 diabetics with chronic kidney disease, which Patel believes will happen, it could force the hand of insurance companies to expand their coverage of the drug.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Two negatives are two positives for the FedOutlook: Today we get import prices, the Philly Fed’s Harker, and the University of Michigan consumer sentiment index(expected down to 67.4 in Oct fro
Weiterlesen »
Two arrested, two sought in connection with shots fired in EnterpriseWith Israeli hostages and Palestinian civilians trapped inside Gaza, overseas family members of innocent people caught in the conflict feel powerless. In Brussels where the European Union is headquartered, our reporter Rosie Birchard met some of those hoping and praying that their loved ones will make it out alive.
Weiterlesen »
Risk-taker's market? Why it may be practical to take chips off the tableTwo market experts tackle the appropriate appetite for risk during market ugliness.
Weiterlesen »
GOP tensions reach a boiling point as Steve Scalise strugglesOne Republican said it would be 'literally a miracle' if they elect a speaker on Thursday.
Weiterlesen »
Miracle Regrowth: How Stopping an Aging Enzyme Can Repair Nerve DamageScience, Space and Technology News 2023
Weiterlesen »
'Miracle healer' Taylor Hall near return to Blackhawks'Miracle healer' Taylor Hall near return to Blackhawks
Weiterlesen »